Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia

NCT00218231 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

NIH

Sponsor class

Conditions

Schizophrenia
Tobacco Use Disorder

Interventions

DRUG: 300 mg/day bupropion-sr
DRUG: 0 mg/day bupropion-sr

Sponsor

National Institute on Drug Abuse (NIDA)